The cancer stem cell subtype determines immune infiltration of glioblastoma

  • Christoph P Beier
  • Praveen Kumar
  • Katharina Meyer
  • Petra Leukel
  • Valentin Bruttel
  • Ines Aschenbrenner
  • Markus J Riemenschneider
  • Athanassios Fragoulis
  • Petra Rümmele
  • Katrin Lamszus
  • Jörg B Schulz
  • Joachim Weis
  • Ulrich Bogdahn
  • Jörg Wischhusen
  • Peter Hau
  • Rainer Spang
  • Dagmar Beier

Related Research units

Abstract

Immune cell infiltration varies widely between different glioblastomas (GBMs). The underlying mechanism, however, remains unknown. Here we show that TGF-beta regulates proliferation, migration, and tumorigenicity of mesenchymal GBM cancer stem cells (CSCs) in vivo and in vitro. In contrast, proneural GBM CSCs resisted TGF-beta due to TGFR2 deficiency. In vivo, a substantially increased infiltration of immune cells was observed in mesenchymal GBMs, while immune infiltrates were rare in proneural GBMs. On a functional level, proneural CSC lines caused a significantly stronger TGF-beta-dependent suppression of NKG2D expression on CD8(+) T and NK cells in vitro providing a mechanistic explanation for the reduced immune infiltration of proneural GBMs. Thus, the molecular subtype of CSCs TGF-beta-dependently contributes to the degree of immune infiltration.

Bibliographical data

Original languageEnglish
ISSN1547-3287
DOIs
Publication statusPublished - 10.10.2012
PubMed 22676416